SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Long Term Provisions | ₹3.30 Cr | ₹2.69 Cr | ₹1.71 Cr | - | - |
What is the latest Long Term Provisions ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹3.30 Cr |
Mar2023 | ₹2.69 Cr |
Mar2022 | ₹1.71 Cr |
Mar2017 | - |
Mar2016 | - |
How is Long Term Provisions of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹3.30 Cr | 22.73 | |
Mar2023 | ₹2.69 Cr | 57.43 | |
Mar2022 | ₹1.71 Cr | 0 | |
Mar2017 | - | 0 | |
Mar2016 | - | - |
Compare Long Term Provisions of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹2,014.4 Cr | 1% | 42.4% | 81.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,519.0 Cr | 1.6% | -2.9% | 17.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,903.0 Cr | 1.5% | 10.4% | 51.9% | Stock Analytics | |
CIPLA | ₹121,669.0 Cr | 2.3% | 1.9% | 2.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,097.0 Cr | 5.7% | 14.1% | 15.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,605.0 Cr | 1.4% | 1.3% | 17% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | 1% |
42.4% |
81.3% |
SENSEX | 1.3% |
2.6% |
7.8% |
You may also like the below Video Courses